Dissecting the mechanism of herpesvirus genome packaging
Dissecting the mechanism of herpesvirus genome packaging
批准号:
10509325
负责人:
Allison Louise Didychuk
金额:
$50.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-25 至 2027-07-31
关键词:
AddressAdoptedAfrica South of the SaharaAntiviral AgentsAreaAwardBacteriophagesBehaviorBiochemicalBiochemistryBiological AssayBiologyBiophysicsCancer EtiologyCapsidChargeComplexCongenital AbnormalityCoupledDNA VirusesDevelopmentDiseaseDissectionDrug TargetingEvolutionFDA approvedFoundationsGenomeGoalsHIVHerpes LabialisHerpes encephalitisHerpesviridaeHigh PrevalenceHomologous GeneHumanHuman Herpesvirus 8Immunocompromised HostIn VitroIndividualInfectionInvestmentsKaposi SarcomaLabelLeadLifeMalignant NeoplasmsMass Spectrum AnalysisMethodologyMethodsMicroscopyMolecularMolecular MotorsMolecular VirologyMonitorMotorMutagenesisNucleic Acid BindingOncogenicPharmaceutical PreparationsPositioning AttributeProcessProteinsProteomicsRegulationResearch PersonnelResourcesRoleStructureSystemTailTechniquesTestingTimeViralViral GenomeViral PackagingViral ProteinsVirusVirus ReplicationVisionWorkbasebiophysical propertiesdrug discoveryhigh rewardhigh riskhuman pathogenin vivoinhibitorinnovationinsightinterestmutation screeningneonatenew therapeutic targetnovelpathogenprogramsreconstitutionresistance mutationscaffoldstructural biologysuccessterminasevirology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Human herpesviruses can cause congenital birth defects in neonates and a wide range of disease in humans,
with particularly devastating effects in immunocompromised individuals. Kaposi's sarcoma-associated
herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma and other cancers, with high prevalence in sub-
Saharan Africa. There is no cure for any herpesvirus; most existing antivirals target a single viral process and
can lead to resistance mutations. The recent development of a herpesviral packaging inhibitor highlights the
viral genome packaging machinery as an attractive target for novel antivirals. The herpesviral packaging
machinery is conceptually similar to that of bacteriophages, yet it has additional complexities that include
factors of unknown function. In this proposal, I outline my vision to understand the molecular mechanism of
herpesvirus packaging. I will determine the function of an essential factor in herpesvirus packaging that has
long evaded mechanistic dissection using state-of-the-art proteomics and microscopy approaches. I will also
develop a new strategy to apply deep mutational scanning approaches to herpesviral proteins. In parallel, I will
determine the structure of the KSHV terminase, the viral molecular motor that packages the viral genome into
the nascent capsid. I will then reconstitute the essential components of the KSHV packaging machinery and
use these to develop an in vitro packaging assay. This assay will be leveraged to screen for new antivirals and
determine the molecular underpinnings of existing drugs that target the packaging machinery. The proposed
studies will build a foundation to address long-standing, fundamental questions in DNA virus packaging and
understand the mechanism of anti-herpesvirals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金